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The role of the multifunctional enzyme CD38 in formation of the Ca2+-mobilizing second messenger
nicotinic acid adenine dinucleotide phosphate (NAADP) was investigated. Gene silencing of CD38 did
neither inhibit NAADP synthesis in intact Jurkat T cells nor in thymus or spleen obtained from CD38
knock out mice. In vitro, both NAADP formation by base-exchange and degradation to 2-phospho
adenosine diphosphoribose were efﬁciently decreased. Thus in vivo CD38 appears to be a NAADP
degrading rather than a NAADP forming enzyme, perhaps avoiding desensitizing NAADP levels in
intact cells.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction degradation of the Ca2+-mobilizing second messengers cADPR,The NAADP signalling system has been shown to be ubiqui-
tously employed for controlling Ca2+ release [1–4]. The most prom-
inent function of NAADP regarding Ca2+ signalling is its pivotal role
as a trigger for the development of global Ca2+ signals. To date,
NAADP is the most potent Ca2+-releasing second messenger: It in-
duces Ca2+ signals at concentrations of 10–100 nM [5]. At the same
time, micromolar concentrations of NAADP desensitize NAADP sig-
nalling [1,2]. Therefore, precise control of the intracellular NAADP
concentration is essential for functional Ca2+ signalling. However,
the molecular mechanisms of NAADP metabolism remain to be
elucidated.
CD38 has been demonstrated to generate NAADP in vitro by the
so-called base-exchange reaction [6]. During this reaction, the nic-
otinamide group of NADP is replaced by nicotinic acid leading to
the synthesis of NAADP. However, this reaction requires an acidic
pH and millimolar concentrations of nicotinic acid. These require-
ments will hardly be met in vivo [7,8]. CD38 is a multifunctional
enzyme which in addition catalyses the hydrolysis of NAD to ADPR,
and to a minor extent also to cADPR [9], and the degradation of
NAADP [10]. Thus, CD38 is able to catalyze the synthesis and/orchemical Societies. Published by E
horibose; ADPR, adenosine
sphoribose; NAADP, nicotinic
receptor; FACS, ﬂuorescenceADPR and NAADP. CD38 has already been shown to have an impact
on the Ca2+ signalling system. To date, this effect is thought to be
due to the cADPR-producing activity of CD38 [11,12]. However, it
is not known which of the different catalytic properties of CD38
is important in vivo.
In the present study, we determined the effect of CD38 knock
down in Jurkat T cells on NAADP synthesising activity and NAADP
degrading activity. Furthermore, the effect of CD38 expression on
the intracellular NAADP concentration in Jurkat T lymphocytes
after stimulation of the TCR/CD3 complex was assessed. Also,
NAADP content of the immunologically important tissues thymus
and spleen was analysed in CD38 knock out and wild type mice.
2. Materials and methods
2.1. Construction of Jurkat T cell clones displaying gene silencing of
Cd38
For prediction of shRNA sequences CD38 cDNA with Acc. No
BC007964 was used with GenScript [http://gensricpt.com] and
siDirect [http://design.rnai.jp] software packages. For construction
of the control sequences CD38, cDNA (Acc. No BC007964) was
inserted into siRNA Sequence Scrambler from GenScript
[http://gensricpt.com]. The ﬁrst shRNA was targeted against the
sequence 50-CCT GAG ATG AGA CAT GTA GA-30 (positions
271–290 in CD38 cDNA, GenBank Acc. No. BC007964), the second
one was against the sequence 50-GGT TAT ACA TGG TGG AAG
AGA-30 (positions 771–791), and both contained the loop sequencelsevier B.V. All rights reserved.
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CGG ATT CAA TGT ATA AGG-30 and for fragment 771 50-GAA GGC
GAT TGA GTA GAA TTG-30. Fragments were ﬁrst cloned into plas-
mid pSIREN RetroQ (BD Clontech, Mountain View CA, USA).
shRNA-inserts and U6 promotor were ampliﬁed via PCR and di-
rectly cloned into plasmid pDsRed2-C1(BD Clontech, Mountain
View CA, USA). After electroporation of wild type Jurkat T cells with
plasmids carrying either shRNA fragment 270 (sh270) or shRNA
fragment 771 (sh771) or the corresponding scrambled control se-
quences, cells were exposed in bulk culture to G418 (800 lg/ml,
Biochrom AG, Berlin) for 8 days. Then, subclones were further se-
lected in the presence of 400 lg/ml G418 using limiting dilution
procedure (0.3 cells/well).
2.2. Preparation of membrane protein
Jurkat T cells were lysed with a Potter Elvehejm-Homogenizer,
cell debris and nuclei were discarded. Membrane protein fractions
were obtained as pellet after 10000g centrifugation (P10 mem-
branes) and dissolved in buffer containing 140 mM NaCl and
20 mM HEPES with pH 7.4.
2.3. Western blot analysis of CD38
For determination of CD38 expression in Jurkat T cells, 60 lg
membrane protein were separated under non-reducing conditions
by SDS–PAGE using a 12.5% gel and transferred onto a PVDF-mem-
brane. Membranes were incubated with anti-CD38 antibody AT1
(1 lg/ml, 12 h; Santa Cruz Biotechnology, Heidelberg, Germany)
and goat anti-mouse horseradish peroxidase conjugate (0.2 lg/
ml, 1 h, Dianova, Hamburg, Germany). Membranes were incubated
for 1 min with ECL solution (Amersham Biosciences; Freiburg,
Germany). Development of ECL-Hyperﬁlm was performed for
2–30 min.
2.4. Determination of NAD-glycohydrolase activity
To determineNAD-glycohydrolase activity, 106 cells/ml of Jurkat
T cells were incubatedwith 100 lM1,N6-etheno-NAD in extracellu-
lar solution (ECS) containing 140 mM NaCl, 5 mM KCl, 1 mM CaCl2,
1 mMMgSO4, 5.5 mM glucose, 1 mM NaH2PO4, 20 mM HEPES with
pH 7.4. Conversion to 1,N6-etheno-ADPR was measured at
kEx = 300 nm and kEm = 410 nm on a ﬂuorescencemicro plate reader
(Inﬁnite M200 with Software i-control, Tecan, Grödig, Austria).
2.5. Determination of NAADP synthase activity
To determine NAADP synthase activity in Jurkat T cells,
500 lg/ml membrane protein were incubated with 1 mM NADP
and 10 mM nicotinic acid in 10 mM NaH2PO4 at pH 5 for 1 h.
Analysis of reaction products was performed by HPLC as detailed
in 2.7.
2.6. Determination of NAADP hydrolase activity
To determine NAADP hydrolase activity in Jurkat T cells,
1 mg/ml membrane protein were incubated with 100 lM NAADP
in buffer containing 40 mM HEPES, 1 mM MgCl2 and 1 mM CaCl2
at pH 7.4 for 30 min. Analysis of reaction products was
performed by HPLC as detailed in 2.7.
2.7. HPLC analysis of nucleotides
Reaction products were analyzed by ion pair RP-HPLC per-
formed on a 250  4.6 mm C18-5l HYPURITY ADVANCE column
(Thermo Fisher Scientiﬁc, Schwerte, Germany) equipped with a10  4 mm guard cartridge ﬁlled with the same material
(Thermo Fisher Scientiﬁc, Schwerte, Germany). Nucleotides were
eluted with a non-linear gradient at a ﬂow rate of 1 ml/min with
buffer containing 20 mM KH2PO4 and 5 mM tetrabutylammonium
dihydrogen phosphate at pH 6 with increasing amounts of metha-
nol. Analysis of NAADP formation was performed at 30 C with the
following gradient (% methanol): 0 min (35), 5 min (35), 13 min
(70), 23 min (70), 25 min (35) and 30 min (35). Analysis of ADPRP
formation was performed at 25 C with the following gradient
(% methanol): 0 min (0), 3 min (0), 30 min (30), 32 min (30),
34 min (0) and 40 min (0). Nucleotides were detected by UV
absorption at k = 260 nm. Identiﬁcation and quantiﬁcation of
nucleotides was accomplished with nucleotide standards.
2.8. Determination of endogenous NAADP
For determination of NAADP from spleen and thymus from
either wild-type or CD38 knock out mice [13] tissues were
removed, rapidly frozen in liquid nitrogen and homogenized in
2 ml trichloroacetic acid (20%, w/v) using a mortar and lysed with
a Potter Elvehejm-Homogenizer (ﬁve strokes at 1500 rpm). The
samples underwent two subsequent freeze thaw cycles, using
liquid nitrogen and thawing at 37 C, and were then centrifuged
(4400g, 10 min, 4 C). The supernatant was divided into two iden-
tical halves (twin samples). One sample was spiked by addition of
15 pmol of NAADP to calculate the recovery. After extraction of tri-
chloroacetic acid using water–saturated diethyl ether, the samples
were freeze-dried for 60 min. The tissue extracts were puriﬁed by
gravity-fed anion-exchange chromatography and NAADP content
was determined using the NAADP cycling assay as described previ-
ously (Gasser et al., 2006). For NAADP determination from cells
2  108 Jurkat T cells were harvested by centrifugation (500g,
5 min) and rinsed with ECS. The cell suspension was divided into
two identical halves (twin samples) and adjusted to 10 ml with
ECS. After 30 min incubation at room temperature, cells in both
parts of the twin sample were stimulated for different periods of
time with OKT3 (10 lg/ml). After centrifugation (960g, 1 min,
4 C), cell pellets were resuspended in 1 ml of ice-cold trichloroace-
tic acid (20%, w/v) and lysed using a Potter Elvehejm-Homogenizer.
Neutralisation, puriﬁcation and NAADP determination of the sam-
ples was performed as described in detail [14].2.9. Data analysis
Data are described as mean ± S.D. Statistical analysis was per-
formed with SPSS employing univariate ANOVA.
3. Results and discussion
Gene silencing of Cd38 was accomplished in Jurkat T cells using
speciﬁcally targeted shRNA constructs. After transfection of the
plasmids into Jurkat T cells, stable clones were obtained by limiting
dilution. Expression of CD38 in Jurkat T cells was assessed by wes-
tern blot analysis (Fig. 1A). Wild type Jurkat T cells and scrambled
control cells (sh270#A and sh771#E) showed high expression of
CD38. On the contrary, cells with gene silencing of Cd38 (sh270#1
and sh771#9) showed a signiﬁcant reduction in CD38 expression
as CD38 was hardly detectable in western blot experiments.
In vitro CD38 has been reported to generate NAADP from NADP
by the base-exchange reaction [6]. Indeed, NAADP was formed by
membrane protein of wild type Jurkat T cells. Knock down of
CD38 resulted in marked reduction of enzyme activity (Fig. 2A).
Enzyme activity of scrambled control cells was in the same range
as obtained in wild type cells (Fig. 2A). Thus, the data demonstrate
powerful gene silencing via our shRNA approach. Our data also
Fig. 1. Down regulation of CD38 expression in Jurkat T cells. Protein expression was
assayed by western blot analysis. 60 lg P10 membrane protein of wild type (wt),
CD38 knock down (sh270#1, sh771#9) and scrambled control cells (sh270#A,
sh771#E) were separated by SDS–PAGE under non-reducing conditions. Western
blot analysis was performed using the anti-CD38 antibody AT1. A representative
experiment out of 4 is shown.
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and sh771#9) should display a defect in formation in endogenous
NAADP, provided that the base-exchange reaction catalyzed by
CD38 is the relevant pathway to form NAADP in vivo.Fig. 2. NAADP synthase and hydrolase activity in Jurkat T cells. (A) NAADP synthase activ
and 10 mM nicotinic acid for 1 h at pH 5 using 500 lg/ml P10 membrane protein of wild
of NAADP was analyzed by RP-HPLC. Data shown are mean ± S.D. (n = 4); ns p > 0.05, ⁄
monitoring ADPRP formation from 100 lM NAADP for 30 min at pH 7.4 using 1 mg/ml P
control cells (scr). Production of ADPRP was analyzed by RP-HPLC. Data shown are meaHowever, NAADP synthesis by CD38 can only take place at
acidic pH and if nicotinic acid is present at an at least ﬁve-fold
excess. It is not clear whether these conditions exist in vivo. When
excess of nicotinic acid is decreased, less NAADP is formed and
ADPRP is produced. This ﬁnding was ﬁrst published by Chini and
Dousa [15] and was also observed in our experiments.
Therefore, NAADP hydrolysis by CD38 was investigated. Incuba-
tion of membrane protein from wild type cells with NAADP at neu-
tral pH resulted in degradation to ADPRP, whereas samples from
CD38 knock down cells showed a very low activity (Fig. 2B). Hence,
CD38 knock down leads to a very high reduction in NAADP hydro-
lyzing activity. Matching scrambled control cells showed enzyme
activities similar to wild type control cells (Fig. 2B).
Additionally, afﬁnity-puriﬁed soluble CD38 expressed in
HEK293 cells catalyzed the degradation of NAADP to ADPRP as
described above for protein preparations of wild type Jurkat T cells
(data not shown). Our data demonstrate that knock down of CD38
diminishes NAADP degradation.
Speciﬁc enzyme activity for the generation of NAADP seemed to
be higher than for the hydrolysis of NAADP. This is true for the
reaction conditions employed in the measurements shown in
Fig. 2A. Formation of NAADP was observed under excess of nico-
tinic acid and acidic pH. Thus, the reaction is driven towards the
products. However, if the conditions are different, e.g. more ‘‘cyto-
sol-like’’ with pH around 7 and low nicotinic acid concentrations,
the NAADP producing base-exchange reaction does not take place.
Furthermore, NAADP hydrolysis was investigated under rather
physiological conditions at pH 7.4 and without further inﬂuence
on the reaction equilibrium.ity in Jurkat T cells was assessed by monitoring NAADP formation from 1 mM NADP
type (wt), CD38 knock down (CD38kd) and scrambled control cells (scr). Production
⁄⁄p < 0.001 ANOVA. (B) NAADP hydrolase activity in Jurkat T cells was assessed by
10 membrane protein of wild type (wt), CD38 knock down (CD38kd) and scrambled
n ± S.D. (n = 3–8); ns p > 0.05, ⁄⁄⁄p < 0.001 ANOVA.
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formation as well as NAADP degradation [6,10]. To assess the role
of CD38 in the NAADP signaling system in vivo, we investigated the
inﬂuence of CD38 expression on intracellular NAADP levels in Jur-
kat T cells. For determination of NAADP levels we used the enzy-
matic cycling assay developed in our laboratory which allows to
speciﬁcally and sensitively analyze NAADP [14]. NAADP levels in
non-stimulated cells seem to be unaffected by gene silencing of
CD38 (Fig. 3A). Stimulation of TCR/CD3 complex in Jurkat T cells
induced a rapid increase in intracellular NAADP levels, which can
be observed in wild type as well as in CD38 knock down cells
(Fig. 3B). Therefore, CD38 is neither necessary for basal NAADP lev-
els nor for TCR/CD3 induced NAADP formation in T cells. Upon a
5 min stimulation of the cells, NAADP levels remained slightly in-
creased. When comparing NAADP levels at this time point, theFig. 3. Determination of intracellular NAADP concentration. (left) Quantiﬁcation of end
(sh270#1, sh771#9) and scrambled control cells (sh270#A, sh771#E) were measured by
or 5 min (C) after stimulation with anti-CD3 antibody OKT3 (5 lg/ml). Data shown are
NAADP in tissue: (D) CD38 knock out was conﬁrmed by FACS analysis of lymph node c
spleen (F) from wild type (wt) and CD38 knock out mice (CD38 ko) were measured byinﬂuence of CD38 becomes visible. At this time point wild type
and scrambled control cells (sh270#A and sh771#E) displayed a
NAADP concentration of 22 nM whereas CD38 knock down cells
(sh270#1 and sh771#9) showed NAADP concentration of 35 and
34 nM, respectively (Fig. 3C). Although these values are not statis-
tically different between scrambled controls and cells with gene
silencing of CD38, our results indicate a role of CD38 in NAADP
degradation rather than in NAADP formation.
Even though knock down of CD38 in our Jurkat T cell clones was
very high, it was not complete (Fig. 1). We therefore analyzed
NAADP formation in tissues from CD38 knock out mice. FACS anal-
ysis of lymph node cells obtained from CD38 knock out mice ver-
iﬁed the absence of CD38 (Fig. 3D). We compared NAADP levels
in spleen and thymus because of their high content in T cells. In
accordance with the data obtained in CD38 knock down Jurkatogenous NAADP: Intracellular NAADP levels of wild type (wt), CD38 knock down
the enzymatic NAADP cycling assay. Cell extracts were analyzed before (A), 10 s (B)
mean ± S.E.M. (n = 2–4). nd not determined. (right) Quantiﬁcation of endogenous
ells stained with anti-CD38 antibody. Intracellular NAADP levels of thymus (E) and
the enzymatic NAADP cycling assay. Data shown are mean values (n = 2).
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compared to wild type (Fig. 3E and F).
CD38 was proposed to act as a NAADP synthase because it is the
only mammalian enzyme known to catalyze the formation of
NAADP [6]. However, CD38 is an ecto-enzyme and catalyses the
formation of NAADP by the base-exchange reaction which requires
an acidic pH and excess of nicotinic acid. CD38 was reported to be
essential for stimulus induced NAADP production in pancreatic aci-
nar cells [16]. On the other hand, ADP-ribosyl cyclase activity has
been observed in tissues from CD38 knock out mice [17]. Elaborate
studies demonstrated that CD38 is not necessary for the produc-
tion of NAADP since NAADP levels in tissues of CD38 knock out
mice, namely in uterus, liver and spleen, display increased NAADP
levels [18]. This suggests that the absence of CD38 leads to ele-
vated NAADP levels due to the absence of NAADP degrading activ-
ity, at least in selected tissues.
These results were conﬁrmed here both in Jurkat T cells with
gene silencing of CD38 and in tissues from CD38 knock out mice.
ElevatedNAADP levels aremost probably due to reduced expression
of CD38 and therefore to reduced NAADP degrading activity. The
NAADP degrading activity of CD38was conﬁrmed by HPLC analysis.
In contrary to the NAADP synthesising reaction, the NAADP degrad-
ing reaction proceededwell at neutral pH. However, at this stagewe
can not fully exclude secondary effects of CD38 knock down or gene
silencing, e.g. via altered cytosolic NAD or NADP levels.
Our results indicate that synthesis of NAADP in Jurkat T cells
proceeds independently of CD38 expression. On the contrary,
NAADP degradation is reduced when expression of CD38 is silenced
or fully deleted. Thus, NAADP hydrolysis depends, at least in part,
on CD38 expression. We therefore claim that CD38 is not necessary
for NAADP production, but rather catalyses degradation of NAADP.
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